Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Northlea Partners Lllp investment portfolio

Northlea Partners Lllp has made numerous investments in companies such as Newalr&D, Crism Therapeutics, and Tauc3 Biologics within the Healthcare & Life Sciences sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Crism Therapeutics Ltd
CRISM Therapeutics Ltd develops innovative drug‑delivery technologies, such as a hot‑melt extrusion process for manufacturing long‑acting subdermal polymeric implants and the ChemoSeed platform that locally delivers chemotherapy to solid tumours, targeting pharmaceutical manufacturers and oncology treatment providers.
Healthcare & Life SciencesLondonConfirmed2025-10-06
Newalr&D Ltd
NEWALR&D LTD, a UK company, is classified under SIC code 72110, which signifies engagement in research and experimental development on biotechnology. This includes activities such as biology research, biotechnology research, and experimental development on bioinformatics, cell and tissue culture and engineering, DNA/RNA, gene and RNA vectors, nanobiotechnology, and process biotechnology techniques.
Healthcare & Life SciencesLondonConfirmed2025-10-14

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (3)

Northlea Partners Lllp's positions across portfolio companies
2025
2024

Sign up free to see when this investor has bought or sold shares.

+1 more change

Sign up